SynthesisBMJ open2020

Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis.

Joshua Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.